Hello,
I had used tophat2 to map a set of fastq files. I noticed that the reads mapped for some features were different in two separate runs (for eg., ENSMUSG00000047905 produced 4335 reads in one run while it shows only 2 reads in another run), even though I had kept all options constant in both runs. The only change was the annotation file. In the first try, I used the gencode M2 gtf file which contained only level 1 and level 2 features. In the second trial, I had used the complete gtf file. But, the feature (ENSMUSG00000047905) that I am checking has no difference in either annotation files.
Details of ENSMUSG00000047905 in gencode level 1 and level 2 annotation file:
login3$ grep ENSMUSG00000047905 gencode.vM2.annotation.gtf |grep -w gene
chr6 HAVANA gene 67205619 67206083 . + . gene_id "ENSMUSG00000047905.10"; transcript_id "ENSMUSG00000047905.10"; gene_type "pseudogene"; gene_status "KNOWN"; gene_name "Gm8566"; transcript_type "pseudogene"; transcript_status "KNOWN"; transcript_name "Gm8566"; level 2; havana_gene "OTTMUSG00000024710.1";
Details of ENSMUSG00000047905 in gencode complete annotation file:
login3$ grep ENSMUSG00000047905 gencM2_levels1and2.gtf |grep -w gene
chr6 HAVANA gene 67205619 67206083 . + . gene_id "ENSMUSG00000047905.10"; transcript_id "ENSMUSG00000047905.10"; gene_type "pseudogene"; gene_status "KNOWN"; gene_name "Gm8566"; transcript_type "pseudogene"; transcript_status "KNOWN"; transcript_name "Gm8566"; level 2; havana_gene "OTTMUSG00000024710.1";
login3$
What would be the reason for this? Is this expected? Appreciate any help!
Thanks.
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
Latest Articles
Collapse
-
by seqadmin
The complexity of cancer is clearly demonstrated in the diverse ecosystem of the tumor microenvironment (TME). The TME is made up of numerous cell types and its development begins with the changes that happen during oncogenesis. “Genomic mutations, copy number changes, epigenetic alterations, and alternative gene expression occur to varying degrees within the affected tumor cells,” explained Andrea O’Hara, Ph.D., Strategic Technical Specialist at Azenta. “As...-
Channel: Articles
07-08-2024, 03:19 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Yesterday, 06:46 AM
|
0 responses
9 views
0 likes
|
Last Post
by seqadmin
Yesterday, 06:46 AM
|
||
Started by seqadmin, 07-24-2024, 11:09 AM
|
0 responses
26 views
0 likes
|
Last Post
by seqadmin
07-24-2024, 11:09 AM
|
||
Started by seqadmin, 07-19-2024, 07:20 AM
|
0 responses
160 views
0 likes
|
Last Post
by seqadmin
07-19-2024, 07:20 AM
|
||
Started by seqadmin, 07-16-2024, 05:49 AM
|
0 responses
127 views
0 likes
|
Last Post
by seqadmin
07-16-2024, 05:49 AM
|